650 related articles for article (PubMed ID: 34944486)
1. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
2. Identification of Biological Functions and Prognostic Value of NNMT in Oral Squamous Cell Carcinoma.
Zhang W; Jing Y; Wang S; Wu Y; Sun Y; Zhuang J; Huang X; Chen S; Zhang X; Song Y; Hu Q; Ni Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291696
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significances of PLOD2, epithelial-mesenchymal transition markers, and cancer stem cells in patients with esophageal squamous cell carcinoma.
Gong X; Wang A; Song W
Medicine (Baltimore); 2022 Aug; 101(34):e30112. PubMed ID: 36042592
[TBL] [Abstract][Full Text] [Related]
4. Higher Ki67 expression in fibroblast like cells at invasive front indicates better clinical outcomes in oral squamous cell carcinoma patients.
Jing Y; Yang Y; Hao F; Song Y; Zhang X; Zhang Y; Huang X; Hu Q; Ni Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30341240
[No Abstract] [Full Text] [Related]
5. Proteomic Profiling of Paired Interstitial Fluids Reveals Dysregulated Pathways and Salivary NID1 as a Biomarker of Oral Cavity Squamous Cell Carcinoma.
Hsu CW; Chang KP; Huang Y; Liu HP; Hsueh PC; Gu PW; Yen WC; Wu CC
Mol Cell Proteomics; 2019 Oct; 18(10):1939-1949. PubMed ID: 31315917
[TBL] [Abstract][Full Text] [Related]
6. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
[TBL] [Abstract][Full Text] [Related]
7. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-Induced PLOD2 is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Okumura Y; Noda T; Eguchi H; Sakamoto T; Iwagami Y; Yamada D; Asaoka T; Wada H; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Ann Surg Oncol; 2018 Nov; 25(12):3728-3737. PubMed ID: 30105440
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
10. PLOD2-driven IL-6/STAT3 signaling promotes the invasion and metastasis of oral squamous cell carcinoma via activation of integrin β1.
Saito K; Mitsui A; Sumardika IW; Yokoyama Y; Sakaguchi M; Kondo E
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33887877
[TBL] [Abstract][Full Text] [Related]
11. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
12. [Expression of PLOD2 in esophageal squamous cell carcinoma and its correlation with invasion and metastasis].
Di WY; Kang XH; Zhang JH; Wang Y; Kou WZ; Su W
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):102-107. PubMed ID: 30695860
[No Abstract] [Full Text] [Related]
13. PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics.
Sheng X; Li Y; Li Y; Liu W; Lu Z; Zhan J; Xu M; Chen L; Luo X; Cai G; Zhang S
BMC Cancer; 2019 Aug; 19(1):840. PubMed ID: 31455288
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumor-transforming gene 1 (PTTG1) is overexpressed in oral squamous cell carcinoma (OSCC) and promotes migration, invasion and epithelial-mesenchymal transition (EMT) in SCC15 cells.
Zhang E; Liu S; Xu Z; Huang S; Tan X; Sun C; Lu L
Tumour Biol; 2014 Sep; 35(9):8801-11. PubMed ID: 24879625
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
[TBL] [Abstract][Full Text] [Related]
17. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
[TBL] [Abstract][Full Text] [Related]
18. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
19. ADAR1 promotes the epithelial-to-mesenchymal transition and stem-like cell phenotype of oral cancer by facilitating oncogenic microRNA maturation.
Liu X; Fu Y; Huang J; Wu M; Zhang Z; Xu R; Zhang P; Zhao S; Liu L; Jiang H
J Exp Clin Cancer Res; 2019 Jul; 38(1):315. PubMed ID: 31315644
[TBL] [Abstract][Full Text] [Related]
20. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
